ZW191 demonstrates compelling anti-tumor activity in platinum-resistant ovarian cancer patients regardless of FRα expression levelConfirmed ...
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational ...
Everyday Health on MSN
New breakthroughs and emerging treatments for FR-Alpha–positive ovarian cancer
Discover the latest targeted therapies and clinical trials for FR-alpha–positive ovarian cancer, including antibody-drug ...
AbbVie’s (ABBV) ovarian cancer therapy Elahere is OK'd for the U.K.'s National Health Service by the country's health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results